Almost 30,000 people in England with chronic obstructive pulmonary disease (COPD) could soon have access to a biologic treatment, Sanofi and Regeneron's Dupixent, after it was recommended for use by ...
Monday - Friday, 07:00 - 10:00 SIN/HK | 01:00 - 04:00 CET Asia: Monday - Friday, 07:00 - 10:00 SIN/HK Australia: Monday - Friday, 09:00 - 12:00 SYD Europe: Monday - Friday, 0100 - 04:00 CET About ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By James Austin James Austin is a writer covering games and hobbies, which means ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results